Drug-induced hyperbilirubinemia and the clinical influencing factors

  • Ah, Young-Mi; 
  • Kim, Young-Mi; 
  • Kim, Min-Jung; 
  • Choi,Young Hee; 
  • Park, Kyoung-Ho; 
  • 외 2명
Citations

WEB OF SCIENCE

26
Citations

SCOPUS

26

초록

Hyperbilirubinemia may accompany harmful effects such as jaundice, brain dysfunction, and pharmacokinetic alterations of drugs. Clinical drugs are the important causes of hyperbilirubinemia, especially for patients with certain pathologic conditions or with genetic variations. This article reviews hyperbilirubinemic pathophysiology with respect to the effects of clinical drugs. In addition, this review introduces a new formula that may be utilized to estimate the annual occurrences of drug-induced hyperbilirubinemia in a hospital. Variations in the genes of UDP-glucuronosyltransferases, organic anion-transporting polypeptides and multidrug resistance proteins are the predisposing factors for drug-induced hyperbilirubinemia; therefore, their genetic and ethnic polymorphisms are discussed.

키워드

Hyperbilirubinemia; UGT1A1; OATP1B1; Multidrug resistance-associated protein 2 (MRA2); Genetic polymorphisms; Annual occurrence indices; Adverse drug reactions; DUBIN-JOHNSON-SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISMS; ANION TRANSPORTING POLYPEPTIDE; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE; OF-THE-LITERATURE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RENAL-TRANSPLANT RECIPIENTS; RESISTANCE PROTEIN-2 GENE; HEALTHY JAPANESE SUBJECTS; CHOLESTATIC LIVER-INJURY
제목
Drug-induced hyperbilirubinemia and the clinical influencing factors
저자
Ah, Young-Mi; Kim, Young-Mi; Kim, Min-Jung; Choi,Young Hee; Park, Kyoung-Ho; Son, In-Ja; Kim, Sang Geon
DOI
10.1080/03602530802341133
발행일
2008-10
저널명
Drug Metabolism Reviews
권
40
호
4
페이지
511 ~ 537